1 |
Maihofner C, Seifert F, Markovic K: Complex regional pain syndromes: New pathophysiological concepts and therapies. Eur J Neurology 2010; 17: 649-60.
DOI
|
2 |
Mulvaney SW, McLean B, De Leeuw J: The use of stellate ganglion block in the treatment of panic/anxiety symptoms with combat-related post-traumatic stress disorder: preliminary results of long-term follow-up: a case series. Pain Practice 2010; 10: 349-365.
|
3 |
Makharita MY, Amr YM, El-Bayoumy Y: Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia. Pain physician 2012; 15: 467-74.
|
4 |
Treggiari MM, Romand JA, Martin JB, Reverdin A, Rufenacht DA, de Tribolet N: Cervical sympathetic block to reverse delayed ischemic neurological deficits after aneurysmal subarachnoid hemorrhage. Stroke 2003; 34: 961-7.
DOI
|
5 |
Giri S, Nixdorf D: Sympathetically maintained pain presenting first as temporomandibular disorder, then as parotid dysfunction. Text Dent J 2007; 124: 748-52.
|
6 |
Madland G, Feinmann C: Chronic facial pain: a multidisciplinary problem. J Neurol Neurosurg Psychiatry 2001; 71: 716-9.
DOI
|
7 |
Salvaggio I, Adducci E, Dell'Aguila L, Rinaldi S, Marini M, Zappia L, et al: Faical pain: a possible therapy with stellate ganglion block. Pain Med 2008; 9: 958-62.
DOI
|
8 |
Wang QX, Wang XY, Fu Na, Liu JY, Yao SL: Stellate ganglion block inhibits formalin-induced nociceptive responses: mechanism of action. Eur J Anaesthesiol 2005; 22: 913-8.
DOI
ScienceOn
|
9 |
Uchida K, Tateda T, Hino H: Novel mechanism of action hypothesized for stellate ganglion block related to melatonin. Med Hypotheses 2002; 59: 446-9.
DOI
ScienceOn
|
10 |
Bruce J, Tamarkin L, Riedel C, Markey S, Oldfield E: Sequential cerebrospinal fluid and plasma sampling in humans: 24-hour melatonin measurements in normal subjects and after peripheral sympathectomy 1991; 72: 819-23.
DOI
|